The CLP reclassification deadline for substances already on the EU market falls on 1 November 2026 — the day the grace period that has let many companies keep selling a chemical substance with the same safety data sheet for years finally runs out. From that date, any substance already on the EU market before 1 May 2025 has to carry, without exception, the three new hazard classes added by Delegated Regulation (EU) 2023/707: endocrine disruptor, PBT/vPvB (persistent, bioaccumulative and toxic) and PMT/vPvM (persistent and mobile, or very persistent and very mobile). It is not a symbolic date. It is the end of the transition period the regulation itself granted so that reclassification would not have to happen overnight.
Two dates, and which one is yours
Delegated Regulation (EU) 2023/707, which entered into force on 20 April 2023 and amends the CLP Regulation (EC) 1272/2008, sets the general rule at 1 May 2025: from that day, any substance classified or placed on the market for the first time must already carry the three new classes. But the regulation adds the exception that actually matters if you have been selling the same substance for years: a substance already on the market before 1 May 2025 gets an extra eighteen months, and that margin ends on 1 November 2026. For mixtures the calendar shifts by a year — the general obligation starts on 1 May 2026, and mixtures already on the market before that date have until 1 May 2028.
The most common mistake in this kind of review is not failing to notice that the new classes exist. It is assuming that because the substance itself has not changed, the safety data sheet does not need to change either. The classification does change, even with a composition identical to five years ago, because the endocrine-disruption and persistence/mobility criteria are new and simply did not exist when the current SDS was drafted.
What the three new hazard classes actually assess
The endocrine disruptor class splits into two categories, human health and the environment, and is based on whether the substance has an endocrine mode of action, produces an adverse effect, and whether a plausible causal link exists between the two. These criteria are closely modelled on — but not fully identical to — those already used under the Biocidal Products Regulation and the Plant Protection Products Regulation: the underlying human-health and environment criteria are shared, but CLP additionally splits endocrine disruptors into Category 1 (known or presumed) and Category 2 (suspected), a distinction neither of those two regulations makes. The PBT/vPvB classes assess persistence, bioaccumulation and toxicity in aquatic and terrestrial compartments; PMT/vPvM adds mobility, aimed at substances that can reach groundwater and drinking water even when they are not particularly bioaccumulative. A substance can fall into more than one class at once, and each one requires its own statement in sections 2 and 15 of the safety data sheet, plus the relevant pictograms and H-statements if the classification results in a hazard.
In practice, the three classes most often reshuffle the paperwork for solvents, plasticisers, UV filters, flame retardants and resin components — categories where persistence, mobility or hormonal activity had not been formally assessed under the previous version of CLP. A substance that performed perfectly well under the old hazard classes can still trigger the new PMT/vPvM criteria simply because it is soluble enough to reach groundwater, regardless of how it behaves in air or soil; the same substance may turn out to be entirely unaffected by the endocrine disruptor class. That is why a blanket assumption — «we checked this substance years ago and it was fine» — is exactly the gap the new classes are designed to close.
What your company needs to check before the CLP reclassification deadline
The starting point is not the label, it is the classification file. Substance by substance, you need to check whether a harmonised classification already exists in Annex VI of the CLP Regulation that incorporates the new classes, or whether the manufacturer’s or importer’s self-classification needs reviewing against the endocrine disruptor, PBT/vPvB and PMT/vPvM criteria. If the substance turns out to be classified under any of them, the safety data sheet has to be redrafted with the new information across the sixteen sections REACH requires — adding a line to section 2 is not enough — and, if the hazard classification changes, the container has to be relabelled before the next placing on the market. For companies buying a substance from a supplier outside the EU, the usual problem is that the non-EU manufacturer has not carried out this review, and the SDS that arrives still reflects the classification from three years ago: the responsibility for the document being current when the product is placed on the market in the EU sits with the importer, not with the manufacturer in Asia or the Americas who drafted it. This is exactly the gap a CLP reclassification deadline check is meant to close before it becomes an inspection finding.
The question worth asking is not whether the regulation applies to you. If you place a chemical substance or mixture on the EU market, it always applies — what is new is the criteria, not the obligation to classify. The real question is whether your current safety data sheet already incorporates the three classes, or whether it still reads as if Delegated Regulation (EU) 2023/707 did not exist. You can check this yourself before starting a full review against the CLP reclassification deadline: open section 2 of your current SDS and look for an explicit mention of «endocrine disruptor,» «PBT,» «vPvB,» «PMT» or «vPvM.» If none of them appear, that does not mean your substance is free of those classes. It means nobody has evaluated it yet against the new criteria.
If your company imports or manufactures chemical substances or mixtures and your safety data sheet has not been reviewed since Delegated Regulation (EU) 2023/707 came into force, do not wait until 1 November to find out where you stand: get in touch with our team and we will assess the substance against the current criteria and leave the safety data sheet compliant before the deadline closes. You can see when an SDS is mandatory and what it must include in our article on safety data sheets under REACH, and you will find more regulatory updates like this one in our news section.
Frequently asked questions
What happens if my substance was already on the market before 1 May 2025 and I don’t reclassify it in time?
From 1 November 2026 the substance is considered incorrectly classified and labelled if it does not include the new classes it should carry. That can block its placing on the market, and if an inspection follows, it opens the door to a CLP infringement sanction, not just a formal observation.
Do mixtures have the same deadline as substances?
No. For mixtures the general obligation starts on 1 May 2026, a year later than for substances, and mixtures already on the market before that date have until 1 May 2028.
Is it enough if my non-EU supplier sends me an updated SDS?
Not always. A manufacturer outside the EU may not have evaluated the CLP endocrine disruptor or PBT/PMT criteria, because they do not apply directly in its home country. Whoever places the product on the EU market, usually the importer, is responsible for the classification and the SDS reflecting the criteria in force in the EU.